Atorvastatin News and Research

RSS

MIT study reveals circadian impact on drug metabolism in engineered livers

Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.

25 Apr 2024

Substituting meat with Quorn can lower bad cholesterol by 10%

Regularly substituting meat for mycoprotein such as Quorn could help to lower bad cholesterol by 10-percent, which is comparable to switching to a Mediterranean or vegan diet.

4 Mar 2024

Clinical study suggests statins could be key in reducing dementia in individuals with heart failure

The association between statin therapy and the risks of dementia among patients with heart failure.

19 Jan 2024

Study points to the possibility of using cholesterol-lowering drugs to treat aggressive colorectal tumors

Hard-to-detect colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend heavily on the ramped-up production of cholesterol, according to a preclinical study from researchers at Weill Cornell Medicine.

18 Dec 2023

Global study emphasizes early detection of familial hypercholesterolaemia in youth

Study on familial hypercholesterolaemia in children and adolescents from 48 countries highlights the need for early detection and management to prevent cardiovascular diseases.

17 Dec 2023

Targeting cholesterol metabolism for the treatment of serrated colorectal neoplasms

13 Dec 2023

Recaticimab injection every 1-3 months may safely lower bad cholesterol

A new PCSK9 inhibitor (recaticimab) injected every one to three months may work safely and provide more flexible dosing to lower cholesterol, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Study compares two widely used statins for treating patients with coronary artery disease

Two widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary artery disease.

18 Oct 2023

Swapping meat for Quorn protein could reduce cholesterol and trim waist circumference

People looking to reduce their cholesterol and trim fat from around their waist could try swapping meat for Quorn protein, according to the findings from a new study by Northumbria University, Newcastle, published in the European Journal of Nutrition, which saw positive effects in both areas in just two weeks.

28 Sep 2023

Different statin drugs exert different effects on COVID-19 patients

We've all recently gotten a crash-course in drug repurposing, thanks to near-daily news reports about efforts to identify existing medicines that could help treat COVID-19 in the early phase of the pandemic.

9 May 2023

Investigating treat-to-target low-density lipoprotein-cholesterol versus high-intensity statins for coronary artery disease

In a recent study published in JAMA, researchers investigated whether treat-to-target (TTT) low-density lipoprotein-cholesterol (LDL-C) therapy was inferior to administering statins of high intensity for clinical outcomes in the long term among coronary artery disease (CAD) patients.

8 Mar 2023

Mark Cuban has been taking on the drug industry. But which one?

When billionaire Mark Cuban announced his attack on the pharmaceutical industry and its high-priced drugs in January 2021, it was met with cheers.

17 Feb 2023

Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.

28 Nov 2022

Exploring the muscle symptoms associated with statin therapy

In a new study, investigators explored the influences of statin treatment on muscle symptoms.

31 Aug 2022

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

Atorvastatin News and Research

MIT study reveals circadian impact on drug metabolism in engineered livers

Substituting meat with Quorn can lower bad cholesterol by 10%

Clinical study suggests statins could be key in reducing dementia in individuals with heart failure

Study points to the possibility of using cholesterol-lowering drugs to treat aggressive colorectal tumors

Global study emphasizes early detection of familial hypercholesterolaemia in youth

Targeting cholesterol metabolism for the treatment of serrated colorectal neoplasms

Recaticimab injection every 1-3 months may safely lower bad cholesterol

Study compares two widely used statins for treating patients with coronary artery disease

Swapping meat for Quorn protein could reduce cholesterol and trim waist circumference

Different statin drugs exert different effects on COVID-19 patients

Investigating treat-to-target low-density lipoprotein-cholesterol versus high-intensity statins for coronary artery disease

Mark Cuban has been taking on the drug industry. But which one?

Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

Exploring the muscle symptoms associated with statin therapy

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

Study predicts that different statins exhibit divergent effects on host response to SARS-CoV-2 infection

New smartphone app can calculate users’ genetic risk for coronary artery disease

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Commonly prescribed medications can make the flu virus more or less active

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News